SNCA and Parkinson disease: It has been found present in Parkinson’s disease (PD) patient’s Lewy bodies, where it colocalizes with amyloid filaments and soluble α-synuclein and promotes ATP-dependent restriction of α-syn binding to vesicles and fibril formation [94,95].